β-catenin degrader therapy(Parabilis Medicines)

N/A

Report date: 2024/11/04 16:36:07
NME

Base Information

Drug Nameβ-catenin degrader therapy(Parabilis Medicines)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesParabilis Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesParabilis Medicines Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A